[
    {
        "source_PMID": "9742977",
        "questions": [
            " question: Does intensive glucose control with metformin have any specific advantage or disadvantage?",
            " question: What type of advantage or disadvantage does the UKPDS provide?",
            " question: What were the symptoms after 3 months' initial diet?",
            " question: What questions did the secondary analysis generate?",
            " question: What did the increase in FPG cause?",
            " question: Patients allocated metformin had risk reductions of 32% (95% CI 13-47, p=0.002)",
            " question: What are the percentages of diabetes-related death and all-cause mortality?",
            " question: Was early addition of metformin associated with an increased risk of diabetes-related death?",
            " question: Who did not have an increased risk of diabetes-related death in patients treated with a combination of sulphonylurea and metformin?",
            " question: Is metformin associated with less weight gain and fewer hypoglycaemic attacks?",
            " question: What may be the first-line pharmacological therapy of choice in these patients?"
        ]
    },
    {
        "source_PMID": "32891604",
        "questions": [
            " question: What type of questions were generated by the study?",
            " question: What are the guidelines for diabetic kidney disease?",
            " question: What was the prespecified effect of glucose on diabetic kidney disease?",
            " question: How long was the median stay in the hospital?",
            " question: Was there more or less kidney failure in the intensive therapy group?",
            " question: How many questions were generated in the intensive therapy group?",
            " question: What does the analysis of the results of the analysis show?"
        ]
    },
    {
        "source_PMID": "32215272",
        "questions": [
            " question: What type of questions were asked about the effects of combined training?",
            " question: What was the purpose of the study?",
            " question: Which groups received resistance-aerobic training for 3 sessions during eight weeks?",
            " question: What did the results of the combined exercise training show?",
            " question: What did the lower body show a significant increase in strength?",
            " question: Is there a need for more research in this area?"
        ]
    },
    {
        "source_PMID": "30012135",
        "questions": [
            " question: Why are clinicians increasingly avoiding lithium?",
            " question: What percentage of lithium users have an increased risk of chronic kidney disease?",
            " question: What is the purpose of the RCT?",
            " question: Who will be randomly assigned to receive atorvastatin?",
            " question: What is AQP2?",
            " question: In what way could lithium be used in future trials?"
        ]
    },
    {
        "source_PMID": "31295292",
        "questions": [
            " question: What type of questions were raised about therapeutic footwear?",
            " question: What does a rigid rocker sole do?",
            " question: What was the purpose of the study?",
            " question: What type of footwear was used in the study?",
            " question: What was the primary outcome measure?",
            " question: On what basis did ulcer recurrence occur in both control and experimental groups?",
            " question: How long does it take for diabetic foot ulcers to develop?",
            " question: What can be done to reduce the risk of plantar ulcer recurrence?"
        ]
    },
    {
        "source_PMID": "32621644",
        "questions": [
            " question: What is the purpose of the RCTs?",
            " question: What type of RCT is needed for lithium-induced NDI?",
            " question: In what study was UOsm not statistically different between groups?",
            " question: Was atorvastatin statistically different between groups?",
            " question: Was atorvastatin effective in reducing urinary osm?",
            " question: Did atorvastatin 20 mg/d significantly improve urinary osmolality?"
        ]
    },
    {
        "source_PMID": "32321301",
        "questions": [
            " question: What is the purpose of this study?",
            " question: What type of diabetes mellitus was evaluated in the study?",
            " question: How were diabetes patients compared with healthy controls?",
            " question: Was there a statistically significant difference between healthy and diabetes mellitus patients?",
            " question: What was the correlation between HbA1c levels and diabetes mellitus times and endothelial cell densitometer values?",
            " question: What did the endothelial cell densitometer in diabetes mellitus patients with the diagnosis of non-proliferative diabetic retinopathy and proliferating diabetic retinal disease generate?",
            " question: Is there a correlation between retinopathy severity and corneal endothelial cell density?"
        ]
    },
    {
        "source_PMID": "34889293",
        "questions": [
            " question: What is the cause of diabetes mellitus?",
            " question: In addition to amputation, in what other way is moxibustion used?",
            " question: What is the purpose of this study?",
            " question: Who is randomly assigned to the moxibustion group?",
            " question: How long will it take for the waiting group to act as the control group?",
            " question: What is the secondary outcome of this study?",
            " question: What are the results of the trial?"
        ]
    },
    {
        "source_PMID": "7587918",
        "questions": [
            " question: Did intensive glycemic control decrease the frequency or severity of diabetic microvascular complications?",
            " question: Who was randomly assigned to multiple insulin injection treatment groups?",
            " question: Who evaluated the 55 NIDDM patients who showed simple retinopathy?",
            " question: How often were complications evaluated in this study?",
            " question: What does the increase of one or more steps in 3 stages for nephropathy generate?",
            " question: What was the percentage of cumulative percentages of the development and progression in nephropathy after 6 years?",
            " question: What percentage of the MIT group showed significant improvement in the nerves after 6 years?",
            " question: How long did the CIT group show improvement in nerve conduction velocities and vibration threshold?",
            " question: Did diabetic retinopathy improve or worsen in the CIT group?",
            " question: What does NIDDM generate questions about?"
        ]
    },
    {
        "source_PMID": "7598463",
        "questions": [
            " question: What questions did the DCCT generate?",
            " question: What causes hypoglycemia?",
            " question: What type of diabetics are prone to controversy over the use of insulin?"
        ]
    }
]